![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
01 Creative Peptides (1)
02 USP (5)
01 141732-76-5 (1)
02 141758-74-9 (1)
03 1678417-38-3 (1)
04 Blank (3)
01 Exenatide is a 39-amino-acid peptide, an insulin secretagogue, with glucoregulatory effects. Exenatide is a glucagon-like peptide-1 agonist (GLP-1 agonist) medication, belonging to the group of incretin mimetics. Exenatide enhances glucose-dependent insulin secretion by the pancreatic beta-cell, suppresses inappropriately elevated glucagon secretion, and slows gastric emptying. More information please visit the website: http://www.creative-peptides.com/product/exenatide-item-10-101-16-50.html (1)
02 Material Origin- Chemical Synthesis; USMCA- No; KORUS- No (5)
01 U.S.A (6)